Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001013596-10-000075
Filing Date
2010-08-04
Accepted
2010-08-03 18:51:08
Documents
20
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q FOR QUARTER ENDED JUNE 30, 2010 fm10q_3-10.htm 10-Q 369406
2 STATEMENT OF SHARE AND EQUITY CAPITAL EXCHANGE exh3-4.htm EX-3.4 789
3 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION exh3-5.htm EX-3.5 1129
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER exh31-1.htm EX-31.1 16220
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER exh31-2.htm EX-31.2 16218
6 CERTIFICATION OF CHIEF EXECUTIVE AND CHIEF FINANCIAL OFFICERS exh32.htm EX-32 8056
7 sun-img2.jpg GRAPHIC 22731
8 sun-img3.jpg GRAPHIC 11304
9 sun-img1.jpg GRAPHIC 15856
10 sunaoa1a.jpg GRAPHIC 70545
11 sun-aoa5.jpg GRAPHIC 63746
12 sun-aoa7.jpg GRAPHIC 83825
13 sun-aoa8.jpg GRAPHIC 47713
14 sunaoa6a.jpg GRAPHIC 90782
15 sunsaoa2a.jpg GRAPHIC 40729
16 sunaoa3a.jpg GRAPHIC 17278
17 sunsaoa4a.jpg GRAPHIC 69552
18 sunsse1a.jpg GRAPHIC 47012
19 sunsse2a.jpg GRAPHIC 46607
20 sunsse3a.jpg GRAPHIC 45691
  Complete submission text file 0001013596-10-000075.txt   1342895
Mailing Address 6100 ROYALMOUNT AVENUE MONTREAL A8 H4P 2R2
Business Address 6100 ROYALMOUNT AVENUE MONTREAL A8 H4P 2R2 514-496-5197
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 10989042
SIC: 8742 Services-Management Consulting Services